Study on the Diagnostic Value of Needle Cutting Biopsy for the Primary and Metastatic Hepatic Cancer During the Treatment of Radiofrequency Ablation and Ethanol Injection
- VernacularTitle:经皮射频治疗肝癌及其活体穿刺活检结果的实验研究
- Author:
Shujia LIU
;
Minshan CHEN
;
Xianghong CHEN
- Publication Type:Journal Article
- Keywords:
Liver tumor;
Treatment;
Radiofrequency ablation;
Biopsy
- From:
Journal of Chinese Physician
2001;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objectives To investigate the diagnostic value and safety of needle cutting biopsy for the primary and metastatic hepatic cancer during the treatment of percutaneous radiofrequency ablation and ethanol injection guided by ultrosound or CT. Methods The clinical data of 48 patients underwent the treatment of percutaneous radiofrequency ablation and ethanol injection as well as biopsy were analyzed. Results Among 48 patients,46 case(95.8%) were diagnosed by pathological examination and 2 cases (4.2%) failed to be diagnosed. There were no serious complications in all the patients. Conclusion Detachable needle cutting biopsy was safe and effective for the diagnosis of the primary and metastatic hepatic cancer during the treatment of percutaneous radiofrequency ablation and ethanol injection guided by ultrasound or CT.
